Chemoinformaics analysis of (7R)-7-Hydroxylariciresinol
| Molecular Weight | 376.405 | nRot | 6 |
| Heavy Atom Molecular Weight | 352.213 | nRig | 17 |
| Exact Molecular Weight | 376.152 | nRing | 3 |
| Solubility: LogS | -3.088 | nHRing | 1 |
| Solubility: LogP | 0.855 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 12 |
| nHA | 7 | APOL | 55.017 |
| nHD | 4 | BPOL | 29.285 |
| QED | 0.612 |
| Synth | 3.716 |
| Natural Product Likeliness | 1.475 |
| NR-PPAR-gamma | 0.022 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.583 |
| HIA | 0.034 |
| CACO-2 | -5.341 |
| MDCK | 0.0000046 |
| BBB | 0.07 |
| PPB | 0.89145 |
| VDSS | 0.832 |
| FU | 0.168175 |
| CYP1A2-inh | 0.047 |
| CYP1A2-sub | 0.759 |
| CYP2c19-inh | 0.027 |
| CYP2c19-sub | 0.66 |
| CYP2c9-inh | 0.093 |
| CYP2c9-sub | 0.681 |
| CYP2d6-inh | 0.116 |
| CYP2d6-sub | 0.711 |
| CYP3a4-inh | 0.296 |
| CYP3a4-sub | 0.671 |
| CL | 11.162 |
| T12 | 0.854 |
| hERG | 0.208 |
| Ames | 0.078 |
| ROA | 0.072 |
| SkinSen | 0.886 |
| Carcinogencity | 0.054 |
| EI | 0.497 |
| Respiratory | 0.271 |
| NR-Aromatase | 0.715 |
| Antiviral | No |
| Prediction | 0.572767 |